Gregory Grabowski, M.D.

Gregory Grabowski, M.D., has spent a lifetime studying genetic disease, with an emphasis on identifying, treating, and curing various disorders, including Gaucher disease. His research on Gaucher disease is extensive, covering nearly all genetic aspects of the disease.  Dr. Grabowski’s other related research interests contain the study of enzyme, chaperone, and substrate reduction therapies in genetic diseases, predictive genotyping, and weighing the ethical issues in the various Gaucher disease treatment options.

Dr. Grabowski is presently the A. Graeme Mitchell Chair of Human Genetics, and Director of Human Genetics at the Children’s Hospital Research Foundation in Cincinnati, Ohio.  He is also a professor of Microbiology, Biochemistry, and Pediatrics, at the University of Cincinnati College of Medicine.  A graduate of the University of Minnesota, Dr. Grabowski has a long and distinguished educational background. He did his doctoral work at his alma mater, and embarked on his residency in 1974 in the University of Minnesota Department of Pediatrics. Continuing his career at Minnesota, he became a Fellow in Medical Genetics, and an Instructor at the University’s Department of Pediatrics.  In 1979, Gregory left for New York, developing his research career and teaching genetics at the Mt. Sinai School of Medicine.  He left New York in 1992 for Cincinnati, where he works today.

He is an avid writer, and has produced >260 medical publications. The works are varied, ranging textbooks of pediatric gastroenterology to Gaucher Disease: A Century of Delineation and Research, and scholarly journal publications.  He is a regular reviewer of numerous medical journals, including the Journal of Clinical Investigation, Journal of Biological Chemistry, and the American Journal of Human Genetics.  Dr. Grabowski also serves as an associate editor for the journal Molecular Genetics and Metabolism.  Furthermore, he assists on numerous advisory boards, including many NIH and March of Dimes Study Section Committees. He is the founding Chair of the Expert Committee of the Project Hope/Genzyme Gaucher Initiative for providing therapy to afflicted individuals in the developing world, particularly Egypt and China. He has served on that Committee for over a decade.

Dr. Grabowski’s recognition in the medical community is widespread.  He is the recipient of NIH Awards in Individual Fellowship and Research Career Development Awards. He has been continuously funded from the NIH for research on Gaucher disease for over 25 years. In addition, the National Gaucher Foundation bestowed him with the Excellence in Research in Gaucher Disease Award. He is a member of the American Society for Clinical Investigation and the Association of American Physicians.

Dr. Grabowski is a member of the Scientific Advisory Board for the Children’s Gaucher Research Fund.